Sonographic Measurement of Bladder Wall Thickness in Patients With Neurogenic Bladder Dysfunction
NCT ID: NCT01299792
Last Updated: 2024-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2009-08-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In patients with lower urinary tract symptoms due to benign prostate hyperplasia, sonographic measurement of bladder wall thickness has been demonstrated to be able to replace urodynamic testing for the diagnosis of infravesical obstruction.
Hypothesis: measurement of bladder wall thickness in patients with neurogenic bladder dysfunction due to spinal cord injury is closely related to the known risk factors for upper urinary tract deterioration (bladder compliance, detrusor leak point pressure) in this group of patients and can therefore replace urodynamic examination in selected cases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction
NCT02443870
Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord Injury
NCT01601041
Ureteric Jet Doppler Waveforms in Patients With Spinal Cord Injury
NCT05568862
Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele
NCT03550898
Health-related Quality of Life of Patients With Neurogenic Bladder
NCT02179073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
one arm; neurogenic bladder dysfunction
evaluation of the clinical utility of bladder wall thickness as a diagnostic tool in patients with spinal cord injury
sonographic measurement of bladder wall thickness
measurement of bladder wall thickness by ultrasound at different filling states of the bladder during urodynamic investigation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sonographic measurement of bladder wall thickness
measurement of bladder wall thickness by ultrasound at different filling states of the bladder during urodynamic investigation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to understand German language
* willingness and capability to undergo urodynamic testing
* age \> or = 18 years
Exclusion Criteria
* known bladder tumor or bladder stone
* age \< 18 years
* not capable to understand aim and purpose of the examination
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Paraplegic Research, Nottwil
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juergen Pannek, MD
Role: PRINCIPAL_INVESTIGATOR
Swiss Paraplegic Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Swiss paraplecic centre
Nottwil, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK900
Identifier Type: REGISTRY
Identifier Source: secondary_id
2009-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.